Objectives

Our focus towards launching Prevagen® became a reality in September 2007 as a natural supplement. We continue to develop future pharmaceutical applications through Quincy Bioscience. Quincy Bioscience continues researching the role of apoaequorin in stroke disease as well as chronic inflammation like that which is found in arthritis and autoimmune diseases. We have established a well grounded board of directors as well as a developing Scientific Advisory Panel to help us continue to move forward as we plan and grow towards the future.